Coconut

Coconut (Cocos nucifera L.): A Comprehensive Reference

1. Identity: Botanical Names, Natural Source, and Common Forms

1.1 Taxonomic Identity

Cocos nucifera (L.) is an important member of the family Arecaceae (palm family), popularly known as coconut, coco, coco-da-bahia, or coconut-of-the-beach. The plant is an arborescent monocotyledonous tree of around 25 m in height (giant coconut) with a dense canopy. The plant is originally from Southeast Asia (Malaysia, Indonesia, and the Philippines) and the islands between the Indian and Pacific Oceans. From that region, the fruit of the coconut palm is believed to have been brought to India and then to East Africa. After the discovery of the Cape of Good Hope, this plant was introduced into West Africa and, from there, dispersed to the American continent and to other tropical regions of the globe.

1.2 Fruit Structure

The epicarp, which is the outer skin of the fruit, and the mesocarp, which is heavy, fibrous, and tanned when dry, have many industrial uses. The endocarp is the hard dark core. Inside is a solid white albumen of varied thickness, depending on the age of the fruit, and with an oily pulp consistency and a liquid albumen called coconut water that is thick, sweet, and slightly acidic. The edible part of the coconut fruit (coconut meat and coconut water) is the endosperm tissue. At first, the cellular endosperm is translucent and jelly-like, but it later hardens at maturity to become white flesh (coconut meat).

1.3 Common Preparations and Dosage Forms

Coconut yields a wide range of distinct commercial and traditional preparations. The principal forms encountered in dietary supplement and food contexts include:

• Virgin Coconut Oil (VCO): Obtained by wet processing of coconut milk using fermentation, centrifugation, enzymatic extraction, and the microwave heating method.
• Refined Coconut Oil: Produced by dry or wet milling processes from copra (dried coconut meat) or fresh coconut; subjected to deodorization and bleaching.
• Coconut Water: The liquid endosperm of green coconuts (Cocos nucifera L.), which is the most naturally widespread fruit plant on Earth.
• Coconut Milk and Cream: Emulsions produced by pressing grated coconut meat with water.
• Desiccated Coconut: Dried and grated coconut meat, used in food manufacturing and traditional preparations.
• Medium-Chain Triglyceride (MCT) Oil: Medium-chain triglyceride oils are made predominantly of C8:0 (caprylic) and C10:0 (capric) fatty acids, derived from coconut oil or palm kernel oil. Research on medium-chain triglyceride oils has been focused on these synthesized esters of C8 and C10 fatty acids.
• Coconut Flour: Defatted, dried, and ground coconut meat, used as a high-fiber food ingredient.
• Coconut Shell, Husk, and Root: Used in traditional medicine and ethnobotanical preparations.

Every part of the coconut, including the nutrient-rich meat, water, fiber, shell and wood, serves multiple purposes, making it a valuable resource within traditional knowledge systems.

2. Traditional and Historical Use

2.1 Historical Record

Coconut has been recorded in archaeological excavations and epigraphic inscriptions, in Sanskrit scriptures of religious, agricultural, and Ayurvedic importance, and in historical records as well as travelogues of visitors from China, Arab, and Italy. The utilization of coconut oil stretches back over 4,000 years. Discoveries from the ancient Harappan civilization in today's India and Pakistan exhibit signs of coconut use dating back to 2500 BC. It was primarily in Southeast Asia and the Pacific Islands where coconut and coconut oil cultivation and use became extensive, serving as a dietary staple and an essential for cooking and medicinal practices.

Its usefulness and multiplicity of uses has earned it epithets like "Tree of Life," "Tree of Heaven," "Tree of Abundance," and "Kalpavriksha" (a tree that provides all necessities of life).

2.2 Ayurvedic and Indian Tradition

In India, coconut oil has been a cornerstone of Ayurvedic medicine for centuries, revered for its healing properties. In Ayurvedic medicine, it is used in various healing ointments and drinks for its cooling properties. Coconut occupies a special and higher place among the many articles used in religious offerings. In India, no religious offering is considered acceptable without a coconut, and it is used in religious and social ceremonies even in areas where it is not grown.

2.3 Southeast Asian and Indonesian Tradition

The coconut holds a revered place in traditional Indonesian medicine, known locally as jamu. This ancient practice utilizes various parts of the coconut palm, including the fruit, water, and oil, to create remedies believed to promote health. In countries like Thailand, Vietnam, and the Philippines, coconut milk is a key ingredient in curries and desserts, while coconut oil and husks are used in traditional medicine and handicrafts.

2.4 Polynesian and Pacific Island Tradition

In Polynesia and Hawaii, the coconut is not only a vital food source but also a sacred symbol, revered as a "tree of life" provided by the gods. The island communities use it for cooking, making tools, weaving, and even constructing shelters.

2.5 Traditional Medicinal Applications Across Cultures

The traditional uses of C. nucifera span phytochemical compounds isolated from different parts of the plant, and biological activity and toxicological studies. Ethnobotanical records document a variety of traditional therapeutic applications across cultures:

• Skin and wound care: Topical application of coconut oil for skin moisturization, wound healing, and treatment of skin infections, in traditions across South Asia and the Pacific.
• Digestive health: Coconut preparations were used as a detox remedy and appetite suppressant in various regional traditions.
• Oral hygiene: Oil pulling with coconut oil (known as kavala or gandusha in Ayurveda) was practiced in ancient Indian medicine to promote oral hygiene.
• Hair care: Application of coconut oil to the scalp and hair has been practiced across South Asia and the Pacific to condition hair and treat scalp conditions.
• Fever and infections: Coconut water was traditionally used in oral rehydration, and coconut-based preparations were employed to manage fevers and infections in tropical communities.

3. Key Constituents and Active Compounds

3.1 Fatty Acid Composition of Coconut Oil

Coconut oil is composed of the fatty acids: caprylic acid C-8:0 (8%), capric acid C-10:0 (7%), lauric acid C-12:0 (49%), myristic acid C-14:0 (8%), palmitic acid C-16:0 (8%), stearic acid C-18:0 (2%), oleic acid C-18:1 (6%), and 2% of C-18:2 linoleic acid.

Over 50% of the fats in coconut oil are medium-chain fatty acids, such as lauric acid (12:0). Coconut oil is the highest natural source of lauric acid. Because of its high content of saturated fatty acids (92%), coconut oil has always been classified, along with butter, palm oil, and animal fats, as a source of saturated fat.

An important nuance regarding lauric acid's classification and metabolism is noted in peer-reviewed literature: the main fatty acid in coconut oil is lauric acid (C12:0). Lauric acid can be classified as either a medium-chain or a long-chain fatty acid. In terms of digestion and metabolism, however, it behaves more as a long-chain fatty acid because the majority of it (70%–75%) is absorbed with chylomicrons. In comparison, 95% of medium-chain fatty acids are absorbed directly into the portal vein.

3.2 Medium-Chain Triglycerides (MCTs) and Metabolic Pathway

Medium-chain fatty acids (MCFA) are partly metabolized in the mitochondria of the liver to produce ketone bodies, including 3-β-hydroxybutyrate, acetoacetic acid, and acetone, which are then transported to the organs of the body such as the brain, which can use ketones for energy production. Unlike long-chain fatty acids, medium-chain free fatty acids and monoglycerides are absorbed intact from the small intestine and do not undergo degradation and re-esterification processes. They are directly used in the body to produce energy and are widely used in infant formulas, nutritional drinks for athletes, and intravenous lipid infusions.

Because of their absorption characteristics, MCTs have been used since the 1960s in clinical formulas for adult and infant patients who have issues with the absorption of longer chain fats.

3.3 Lauric Acid and Monolaurin: Antimicrobial Constituents

Virgin coconut oil (VCO) contains lauric acid (45 to 52%). By lipase in the digestive system, VCO can undergo a breakdown into lauric acid, 1-monolaurin, and 2-monolaurin. These components have both hydrophilic and lipophilic groups and are also recognized as excellent antimicrobial lipids. Among MCFAs, lauric acid (LA) and its monoglyceride derivative, glycerol monolaurate (GML), exhibit the strongest antimicrobial activity.

Lauric acid and monolaurin can be used as antibacterial, antifungal, and antiviral with broad-spectrum inhibition. Lauric acid and monolaurin have a strong ability to destroy gram-positive bacteria, especially S. aureus, fungi such as C. albicans, and viruses including vesicular stomatitis virus (VSV), herpes simplex virus (HSV), and visna virus (VV).

3.4 Constituents of Coconut Water

The wide applications of coconut water can be justified by its unique chemical composition of sugars, vitamins, minerals, amino acids, and phytohormones. Young coconut water consists of approximately 95.5% water and contains essential nutrients such as proteins, fats, vitamin C, and B-complex vitamins. It is also abundant in key minerals, including nitrogen, phosphorus, potassium, sodium, magnesium, chlorine, sulfur, iron, and natural electrolytes — particularly sodium, potassium, chloride, calcium, and magnesium.

Electrolytes in coconut water include potassium, sodium, and manganese. The amounts vary by brand.

3.5 Phenolic Compounds (Coconut Testa)

The brown testa (seed coat) of the coconut kernel is particularly rich in polyphenols. Phytochemical analysis confirmed the presence of key antioxidant compounds, while GC-MS analysis identified 21 bioactive constituents in coconut root and testa-derived preparations studied in ethnomedicinal research.

4. Scientific Evidence by Area of Use

4.1 Cardiovascular Risk Factors and Lipid Profiles

Evidence strength: Moderate (clinical trials and meta-analyses exist, but evidence is mixed and the majority of trials are short-term with limitations; no RCTs on hard cardiovascular endpoints).

No randomized controlled trials (RCTs) and/or prospective cohort studies have investigated the effect or association of coconut oil with cardiovascular disease. Available evidence comes from RCTs assessing surrogate lipid markers.

A key 2020 systematic review and meta-analysis published in Circulation: investigators conducted a meta-analysis of clinical trials published by June 2019 that compared coconut oil, consumed for at least 2 weeks, with other vegetable oils. Pooled results of 17 trials involving 730 participants indicated that, compared with other nontropical vegetable oils, coconut oil was associated with significantly increased LDL by a mean of 10.5 mg/dL and HDL by a mean of 4 mg/dL.

A separate RCT (Khaw et al., 2018, BMJ Open) using a three-arm crossover design in generally healthy adults found: LDL-C concentrations were significantly increased on butter compared with coconut oil and with olive oil, with no differences in change of LDL-C in coconut oil compared with olive oil. Coconut oil significantly increased HDL-C compared with butter and olive oil.

In a randomized controlled trial, consumption of 30 g/day virgin coconut oil improved HDL-cholesterol and triacylglycerols, but worsened LDL-cholesterol and total cholesterol.

A 2022 systematic review and meta-analysis of RCTs concluded: coconut oil intake was associated with a small increase in high-density lipoprotein cholesterol (HDL-C) (MD 3.28 mg/dL, 95% CI 0.66 to 5.90 mg/dL). Overall risk of bias was high, and certainty of evidence was very low. Study limitations include the heterogeneity of intervention methods, in addition to small samples and short follow-ups. Coconut oil intake revealed no clinically relevant improvement in lipid profile and body composition compared to other oils/fats.

The mechanistic rationale for the cholesterol-elevating effect: a recent systematic review showed that lauric, myristic, and palmitic fatty acids — the major components of coconut oil — are responsible for the highest increase in LDL-C levels, which is a major risk factor for CVD.

The 2020 meta-analysis in Circulation further estimated the clinical significance: the 10.47 mg/dL increase in LDL-cholesterol resulting from the replacement of nontropical vegetable oils with coconut oil may translate to a 6% increase in risk of major vascular events and a 5.4% increase in the risk of coronary heart disease mortality.

4.2 Antimicrobial Activity

Evidence strength: Moderate in vitro; limited human clinical data; one small clinical RCT in oral/periodontal health.

A randomized clinical trial investigated the effects of coconut oil on the oral microbiome and inflammatory response in patients with periodontitis. Coconut oil is composed of fatty acids such as lauric acid and monolaurin, which have antibacterial activity. Beyond its direct antimicrobial activities, lauric acid can be converted in the body to monolaurin (glycerol monolaurate), a compound similarly reported to have strong inhibitory effects on various pathogenic organisms.

A double-blind controlled trial in adult atopic dermatitis patients compared virgin coconut oil (VCO) with virgin olive oil (VOO), both applied twice daily. Staphylococcus aureus cultures and objective-SCORAD severity index (O-SSI) scoring were done at baseline and after 4 weeks. Of those on VCO, 20 were positive for S. aureus colonies at baseline versus 12 on VOO. Post-intervention, only 1 (5%) VCO subject remained positive versus 6 (50%) of those on VOO.

Monolaurin can also destroy very dangerous viruses such as respiratory syncytial virus (RSV), human immunodeficiency virus (HIV), and novel coronavirus (nCov-19), while lauric acid has the potential to kill Junin virus (JUNV) — though these findings are largely based on in vitro data and require confirmation in clinical trials.

4.3 Dermatology: Atopic Dermatitis and Skin Barrier Function

Evidence strength: Moderate; supported by a small number of RCTs.

A randomized, double-blind clinical trial (Evangelista et al., 2014, International Journal of Dermatology) evaluated topical virgin coconut oil in children with mild to moderate atopic dermatitis: the VCO group achieved a post-treatment mean TEWL (transepidermal water loss) of 7.09 from a baseline mean of 26.68, whereas the mineral oil group demonstrated baseline and post-treatment TEWL values of 24.12 and 13.55, respectively. In the VCO group, post-treatment skin capacitance rose to 42.3 from a baseline mean of 32.0. Thus, among pediatric patients with mild to moderate atopic dermatitis, topical application of VCO for eight weeks was superior to that of mineral oil based on clinical (SCORAD) and instrumental (TEWL, skin capacitance) assessments.

In vitro mechanistic research has clarified how VCO may exert its skin effects: topical application of VCO brings anti-inflammatory activity by inhibiting various cytokine levels including TNF-α, IFNγ, IL-6, IL-5 and IL-8, and improves skin barrier function by up-regulating AQP-3, filaggrin, and involucrin mRNA expression, and also by protecting against UVB irradiation.

A review published in JAAD Reviews (2024) noted: coconut oil consistently showed positive results, while other oils displayed either negative or mixed outcomes. However, the evidence for all topical oils remains limited, highlighting the need for further studies before making definitive recommendations.

4.4 Hydration and Exercise Performance (Coconut Water)

Evidence strength: Moderate; supported by small RCTs; effects generally comparable to sports drinks but not superior to water for basic hydration.

A crossover RCT (Ismail et al., PMC, 2023) in 19 experienced cyclists: this study determined if drinking coconut water compared to a sports drink altered cycling performance and physiology. In a randomized crossover trial, 19 experienced male and female cyclists completed two experimental trials, consuming either a commercially available sports drink or iso-calorific coconut water during 90 min of sub-maximal cycling, followed by a simulated 20 km time trial. There were no significant differences (p ≥ 0.05) between the treatments for any of the measured physiological or performance variables. Additionally, the effect size analysis showed only trivial differences between the treatments for all the measured variables, except blood glucose, which was lower in the coconut water trial compared to the sports drink trial. Consuming coconut water had a similar effect on the cycling time trial performance and the physiological responses to consuming a commercially available sports drink.

An earlier RCT (Sunderland et al., 2011) in 12 exercise-trained men found: subjects lost approximately 1.7 kg (~2% of body mass) during dehydrating exercise and regained this amount in a relatively similar manner following consumption of all conditions. No differences were noted between coconut water and sports drink for any measures of fluid retention. Regarding exercise performance, no significant difference was noted between conditions. In general, subjects reported feeling more bloated and experienced greater stomach upset with the coconut water conditions.

The Mayo Clinic summarizes the clinical picture: some evidence suggests that coconut water may compare to having a sports drink, but coconut water is no more hydrating than plain water.

A potential nephrology application was explored in a pilot study: coconut water was studied for its effects on urinary citrate in volunteers without nephrolithiasis. Coconut water has long been touted for its medicinal qualities including natural hydration. Researchers sought to determine whether its consumption would induce changes to urinary lithogenic factors beyond changes in urine volume.

4.5 Neurological Health: Alzheimer's Disease and Cognitive Function

Evidence strength: Weak to preliminary; mechanistic rationale is established for MCTs, but clinical evidence for whole coconut oil in Alzheimer's disease (AD) is very limited, deriving largely from small pilot studies.

The proposed mechanism: coconut oil has a unique fatty acid composition that is rich in MCFAs, a major portion of which directly reaches the liver via the portal vein, thereby bypassing the lymphatic system. Given that brain glucose hypometabolism is a major early hallmark of AD, detectable well before the onset of symptoms, ketone bodies from MCFA metabolism can potentially serve as an alternative energy source to compensate for lack of glucose utilization in the brain.

A 2024 systematic review and meta-analysis (MDPI Diseases): this study highlights the role of coconut oil as a source of MCTs, which may promote the production of ketone bodies, providing an alternative energy source for brain cells. Interest in coconut oil as a potential dietary intervention has surged owing to its substantial MCT content. Seven studies met the predetermined eligibility criteria.

A small pilot RCT (De la Rubia Ortí et al.) found: 44 institutionalized patients with moderate to severe AD were randomized to isocaloric Mediterranean diets with either 40 mL of coconut oil or no coconut oil for 21 days. The group that received coconut oil in addition to the Mediterranean diet improved episodic memory, temporal orientation, and semantic memory from baseline. The control group had no change in cognitive test performance. The authors observed a more robust cognitive response to the intervention in females with moderate AD, although improvements were observed in both sexes across the spectrum of AD severity.

Regarding MCT oil (as distinct from whole coconut oil): in mild-moderate AD patients, the oral intake of MCT (>95% C8; C8 and C10) resulted in increased plasma ketone body (βHB) concentrations, which was associated positively with cognitive performance. MCT oil is a nutritional source of ketones. This study suggests consistent MCT oil intake stabilizes cognition in AD subjects, especially in mild to moderate disease.

However, important research gaps are acknowledged: it is not clear whether ketone bodies produced from coconut oil have a direct effect on AD, specifically in relation to slowing or clearance of Aβ and τ pathologies — and if so, under what conditions. Furthermore, research needs to be conducted to quantify the yield of ketones from VCO, and to support the ability of coconut derivatives to cross the blood-brain barrier, to establish likely efficacy. Despite coconut being a promising dietary intervention, incorporation of coconut oil in diets in the long run and its influence on neuronal function and survival, as well as cardiovascular effects, remains unknown.

5. Body Systems and Health Areas Associated with Coconut

• Cardiovascular system: Coconut oil affects serum lipid profiles (notably LDL-C and HDL-C); the net clinical effect on cardiovascular outcomes in humans has not been determined by long-term trials.
• Skin and integumentary system: Topical VCO has demonstrated efficacy as a moisturizer and emollient, and has shown antimicrobial activity against S. aureus in atopic dermatitis in clinical trials.
• Neurological system: Via ketone body production from MCTs, coconut oil has been investigated as a metabolic support in AD; evidence is preliminary.
• Immune and antimicrobial function: Lauric acid and monolaurin from VCO show broad-spectrum antimicrobial properties in vitro and in limited clinical studies.
• Musculoskeletal and exercise physiology: Coconut water has been studied as a rehydration and electrolyte-replacement beverage during exercise; evidence supports non-inferiority compared to commercial sports drinks.
• Urinary/renal system: Coconut water has been explored for its effect on urinary citrate, relevant to kidney stone prevention, in a small human study.
• Oral health: Virgin coconut oil has been studied as an adjunct therapy in periodontal treatment based on its antimicrobial properties.
• Gastrointestinal system: Clinically, coconut water may be used as an oral rehydration aid to replace fluid loss from the gastrointestinal tract in patients suffering severe dehydration due to diarrhea.
• Energy metabolism: MCTs from coconut oil are used clinically in patients with malabsorption syndromes and have been used in clinical nutrition formulas since the 1960s.

6. Dosage Forms and Dosages Reported in Studies

The following dosages are reported specifically as they appear in sourced human studies:

• Coconut oil (oral, cardiovascular lipid trials): 30 g/day of virgin coconut oil was used in one RCT assessing metabolic syndrome components.
• Coconut oil (oral, Alzheimer's pilot study): 40 mL of coconut oil per day, added to a Mediterranean diet, for 21 days, in 44 patients with moderate to severe AD.
• Coconut water (rehydration, exercise trials): Following a 60-minute bout of dehydrating treadmill exercise, 12 exercise-trained men received fluid amounts based on body mass loss during the dehydrating exercise, in a crossover design. In one study, a volume of liquids equivalent to 120% of water loss was administered, dosed as 50% before exercise, 40% during exercise, and 30% post-exercise.
• Coconut water (kidney stone pilot study): Participants consumed 1.92 L of either pure coconut water or tap water daily for four days per phase.
• Topical VCO (atopic dermatitis, pediatric RCT): Applied twice daily for 8 weeks.
• Topical VCO (adult atopic dermatitis RCT): Applied twice daily at two non-infected skin sites for 4 weeks.
• Virgin coconut oil (periodontal adjunctive therapy): Pure virgin coconut oil with 47.92% C12:0 was used for the study as a mouthrinse.

7. Safety Considerations and Notable Interactions

7.1 Cardiovascular Safety: LDL Cholesterol and AHA Position

Because coconut oil increases LDL cholesterol, a cause of CVD, and has no known offsetting favorable effects, the American Heart Association advises against the use of coconut oil. According to a scientific guideline statement issued by the AHA in 2017, saturated fats such as coconut oil and other oils that are tropically derived should be replaced with unsaturated fatty acids. Coconut oil was found to elevate LDL cholesterol levels in seven studies reviewed by the AHA, and the AHA recommended that coconut oil should be avoided and all saturated fat limited.

However, the evidence picture is not entirely one-sided. A 2025 analysis of 26 studies found: overall, coconut oil consumption gives variable total cholesterol and LDL-C values, but that HDL-cholesterol values increase and triglycerides decrease. This holistic lipid assessment, together with the consideration of lipid ratios, suggests that coconut oil does not necessarily pose a health risk for heart disease. Researchers continue to debate the clinical significance of simultaneous LDL and HDL increases.

7.2 Cooking Temperature: Smoke Point Considerations

Coconut oil is suitable for single-use shallow frying, although it is not recommended for continuous deep-fat frying because of its low smoke point, which may lead to the production of potentially carcinogenic substances upon overheating.

7.3 Gastrointestinal Adverse Effects

In general, subjects in one exercise hydration study reported feeling more bloated and experienced greater stomach upset with the coconut water conditions compared to bottled water or sports drinks.

7.4 Allergy

People with an allergy to any form of coconut, palm kernel oil, milk, or soy should avoid coconut products altogether. Coconut allergy, while less common than other tree nut allergies, has been documented in the scientific literature.

7.5 Metabolic and Long-Term Safety Concerns

Unlike other types of oils which were consistently proven to prevent weight gain, diabetes, CVD, and mortality, studies that analyzed how coconut oil intake affects weight, lipid, and glycemic levels are mostly based on small, short-term observational studies and clinical trials. The long-term effects of high coconut oil intake therefore remain incompletely characterized.

Concerns about acidosis, hypocalcemia, hyperlipidemia, insulin resistance, and carcinogenesis have been identified in research when large amounts of calories are derived from ketone-promoting foods including coconut oil.

7.6 Replacing Other Dietary Fats

Lowering saturated fat intake does not always lead to an improved lipid profile, especially if the saturated fat is replaced with carbohydrates. This points to the importance of considering the replacement fat, as well as the comparator fat or fat source, when interpreting studies related to fatty acids and disease outcomes. The AHA and other organizations maintain their overall recommendations to lower saturated fat intake while further clarifying that what the saturated fats are replaced with is important, and that replacement should be with vegetable-based polyunsaturated and monounsaturated fatty acids.

7.7 MCT vs. Whole Coconut Oil: A Critical Distinction

Research on manufactured medium-chain triglycerides in the literature cannot be applied to coconut oil because the triglycerides predominant in coconut oil are different in their structure, absorption, and metabolism. This is a recurring methodological limitation in the literature: positive findings for MCT oil supplementation should not be extrapolated to whole coconut oil.

References

• Cocos nucifera (L.) (Arecaceae): A phytochemical and pharmacological review — PMC/NCBI
• The Chemical Composition and Biological Properties of Coconut (Cocos nucifera L.) Water — PMC/NCBI (Yong et al., 2009)
• Coconuts and Health: Different Chain Lengths of Saturated Fats Require Different Consideration — PMC/NCBI
• Coconut oil and palm oil's role in nutrition, health and national development: A review — PMC/NCBI
• Coconut oil consumption and cardiovascular risk factors in humans — PMC/NCBI
• The Effect of Coconut Oil Consumption on Cardiovascular Risk Factors — Circulation / AHA Journals (Neelakantan et al., 2020)
• Dietary Fats and Cardiovascular Disease: A Presidential Advisory from the American Heart Association — Circulation (2017)
• Coconut Oil and Heart Health — Circulation / AHA Journals
• The effects of coconut oil on the cardiometabolic profile: a systematic review and meta-analysis of randomized clinical trials — PMC/NCBI
• Coconut Oil and Cardiovascular Disease Risk — Current Atherosclerosis Reports/PMC
• Randomised trial of coconut oil, olive oil or butter on blood lipids and other cardiovascular risk factors — BMJ Open (Khaw et al., 2018)
• Are We Nuts Over Coconuts? Studying the Effects of Coconut Oil on LDL and Cardiovascular Diseases — PMC/NCBI
• Antimicrobial Properties of Lauric Acid and Monolaurin in Virgin Coconut Oil: A Review — ChemBioEng Reviews (Nitbani et al., 2022)
• Anti-inflammatory and antimicrobial efficacy of coconut oil for periodontal pathogens: a triple-blind randomized clinical trial — PMC/NCBI
• Novel antibacterial and emollient effects of coconut and virgin olive oils in adult atopic dermatitis — PubMed (Verallo-Rowell et al., 2008)
• The effect of topical virgin coconut oil on SCORAD index, transepidermal water loss, and skin capacitance in mild to moderate pediatric atopic dermatitis — International Journal of Dermatology (Evangelista et al., 2014)
• In vitro anti-inflammatory and skin protective properties of Virgin coconut oil — PMC/NCBI
• A review of topical oils on the skin — JAAD Reviews (2024)
• Coconut Water: A Sports Drink Alternative? — PMC/NCBI (2023)
• Comparison of coconut water and a carbohydrate-electrolyte sport drink on measures of hydration and physical performance in exercise-trained men — PMC/NCBI
• Coconut Water: An Unexpected Source of Urinary Citrate — PMC/NCBI
• Impact of Coconut Oil and Its Bioactive Metabolites in Alzheimer's Disease and Dementia: A Systematic Review and Meta-Analysis — PMC/NCBI (2024)
• Potential of coconut oil and medium chain triglycerides in the prevention and treatment of Alzheimer's disease — ScienceDirect
• Use of medium chain triglyceride (MCT) oil in subjects with Alzheimer's disease: A randomized, double-blind, placebo-controlled, crossover study — PMC/NCBI
• Improvement of Main Cognitive Functions in Patients with Alzheimer's Disease after Treatment with Coconut Oil Enriched Mediterranean Diet: A Pilot Study — PubMed
• Dietary Neuroketotherapeutics for Alzheimer's Disease: An Evidence Update — PMC/NCBI
• The role of dietary coconut for the prevention and treatment of Alzheimer's disease: potential mechanisms of action — British Journal of Nutrition
• Triglycerides of medium-chain fatty acids: a concise review — PMC/NCBI
• Coconut — History, uses, and folklore — ResearchGate
• Coconut Oil — The Nutrition Source, Harvard T.H. Chan School of Public Health
• Coconut water: Is it super hydrating? — Mayo Clinic
• Analysis of 26 Studies of the Impact of Coconut Oil on Lipid Parameters: Beyond Total and LDL Cholesterol — MDPI Nutrients (2025)